C

Coeptis Therapeutics Holdings
D

COEP

19.000
USD
0.20
(1.06%)
مفتوح الان
حجم التداول
8
الربح لكل سهم
-0
العائد الربحي
-
P/E
-3
حجم السوق
101,462,109
الأخبار المقالات

العنوان: Coeptis Therapeutics Holdings Inc

القطاع: Healthcare
الصناعة: Biotechnology
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.